Alpha and Delta variants and vaccination effectiveness against severity in COVID-19 inpatients based on medical claims in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alpha and Delta variants and vaccination effectiveness against severity in COVID-19 inpatients based on medical claims in Japan

Published:2023-08-27 Issue:1 Volume:3 Page:28-36
ISSN:2436-293X
Container-title:GHM Open
language:en
Short-container-title:GHM Open

Author:

Mitsushima Shingo¹,Horiguchi Hiromasa²,Taniguchi Kiyosu³

Affiliation:

1. Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.

2. Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Tokyo, Japan.

3. National Hospital Organization Mie National Hospital, Mie, Japan.

Publisher

National Center for Global Health and Medicine (JST)

Link

https://www.jstage.jst.go.jp/article/ghmo/3/1/3_2023.01005/_pdf

Reference28 articles.

1. 1. Sawakami T, Karako K, Song P, Sugiura W, Kokudo N. Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures. Biosci Trends. 2021; 15:257-261.

2. 2. Karako K, Song P, Chen Y, Karako T. An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan? Biosci Trends. 2022; 16:371-373.

3. 3. Karako K, Song P, Chen Y, Tang W, Kokudo N. Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021. Biosci Trends. 2021; 15:1-8.

4. 4. Song P, Karako T. The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022. Biosci Trends. 2022; 15:350-352.

5. 5. Ong SWX, Chiew CJ, Ang LW, et al. Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta). Clin Infect Dis. 2022; 75:e1128-e1136.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching;F1000Research;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3